Progranulin correlated with rapid progressive interstitial lung disease in dermatomyositis with anti-melanoma differentiation-associated gene 5 antibody

被引:0
作者
Li Shanshan
Zhang Yamei
Zhang Ling
Lu Xin
Wang Guochun
机构
[1] China-Japan Friendship Hospital,Department of Rheumatology
[2] China-Japan Friendship Hospital,Department of Radiology
来源
Clinical Rheumatology | 2022年 / 41卷
关键词
Dermatomyositis; Melanoma differentiation-associated gene 5; Rapidly progressive interstitial lung disease; Progranulin;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:757 / 763
页数:6
相关论文
共 150 条
[11]  
Wen X(2004)119th ENMC international workshop: trial design in adult idiopathic inflammatory myopathies, with the exception of inclusion body myositis, 10–12 October 2003, Naarden The Netherlands Neuromuscul Disord 14 337-109
[12]  
Huang K(2011)Myositis-related interstitial lung disease and antisynthetase syndrome J Bras Pneumol 37 100-364
[13]  
Vinik O(2016)Serum progranulin irrelated with Breg cell levels, but elevated in RA patients, reflecting high disease activity Rheumatol Int 36 359-484
[14]  
Shojania K(2013)Expression level of the growth factor progranulin is related with development of systemic lupus erythematosus Diagn Pathol 8 88-516
[15]  
Yeung J(2011)The growth factor progranulin binds to TNF receptors and is therapeutic against inflammatory arthritis in mice Science 332 478-513
[16]  
Shupak R(2017)Serum progranulin levels in Hispanic rheumatoid arthritis patients treated with TNF antagonists: a prospective, observational study Clin Rheumatol 36 507-1564
[17]  
Nimmo M(2011)Granulin is a soluble cofactor for toll-like receptor 9 signaling Immunity 34 505-2152
[18]  
Jian J(2012)Serum progranulin levels are elevated in patients with systemic lupus erythematosus, reflecting disease activity Arthritis Res Ther 14 R244-2918
[19]  
Konopka J(2017)Progranulin as a biomarker and potential therapeutic agent Drug Discov Today 22 1557-409
[20]  
Liu C(2019)Successful classification of macrophage-mannose receptor CD206 in severity of anti-MDA5 antibody positive dermatomyositis associated ILD Rheumatology (Oxford) 58 2143-820